These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 277162)

  • 41. [Allogenic blood transfusion for surgery].
    Inaba S
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):13-7. PubMed ID: 15696693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transfusion in palliative care in child with malignant disease].
    Munzer M
    Transfus Clin Biol; 2010 Dec; 17(5-6):353-6. PubMed ID: 21051262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the concordance between guidelines and transfusion practices in neonatal intensive care units].
    Royon V; Lardennois C; Maréchal I; Dureuil B; Marret S; Laudenbach V
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):517-22. PubMed ID: 22464838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Indications for blood transfusion].
    Hollán Z
    Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636
    [No Abstract]   [Full Text] [Related]  

  • 45. Guidelines for red blood cells and plasma transfusion for adults and children: an emergency physician's overview of the 1997 Canadian blood transfusion guidelines. Part 1: red blood cell transfusion. Canadian Medical Association Expert Working Group.
    Innes G
    J Emerg Med; 1998; 16(1):129-31. PubMed ID: 9472774
    [No Abstract]   [Full Text] [Related]  

  • 46. How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity.
    Strauss RG
    Transfusion; 2008 Feb; 48(2):209-17. PubMed ID: 18194380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Indications for transfusion].
    Hollán Z
    Orv Hetil; 1988 Feb; 129(6):271-6, 279. PubMed ID: 3347478
    [No Abstract]   [Full Text] [Related]  

  • 48. Strategies for the review of transfusion practices.
    Silberstein LE; Kruskall MS; Stehling LC; Johnston MF; Rutman RC; Samia CT; Ramsey G; Eisenstaedt RS
    JAMA; 1989 Oct; 262(14):1993-7. PubMed ID: 2506369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mode of preparation of labile blood products--available products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1314-20. PubMed ID: 10442066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A survey of blood transfusion practice in French-speaking pediatric anesthesiologists.
    Jouffroy R; Baugnon T; Carli P; Orliaguet G
    Paediatr Anaesth; 2011 Apr; 21(4):385-93. PubMed ID: 21299685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The transfusion of blood and its derivatives in the neonate].
    Mercado-Arellano A; Farfán-Canto JM; González-Cabello H; Alvarez-Amaya C; Jasso-Gutiérrez L
    Bol Med Hosp Infant Mex; 1991 Nov; 48(11):836-40. PubMed ID: 1768362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Indications and utilization of labile blood products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1321-6. PubMed ID: 10442067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parsimonious blood use and lower transfusion triggers: What is the evidence?
    Auron M; Duran Castillo MY; Kumar A
    Cleve Clin J Med; 2017 Jan; 84(1):43-51. PubMed ID: 28084984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood component use in critically ill patients.
    Rao MP; Boralessa H; Morgan C; Soni N; Goldhill DR; Brett SJ; Boralessa H; Contreras M;
    Anaesthesia; 2002 Jun; 57(6):530-4. PubMed ID: 12010265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anemia and blood transfusion].
    Nevanlinna HR
    Duodecim; 1981; 97(7):369-71. PubMed ID: 7274109
    [No Abstract]   [Full Text] [Related]  

  • 58. Red blood cell and platelet transfusions in the treatment of anemic thrombocytopenic patients.
    Valeri CR; Ragno G
    Transfusion; 2006 Dec; 46(12):2210-1; author reply 2211-2. PubMed ID: 17176338
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Erythrocyte concentrates. Indications and applications].
    Kocher P
    Ther Umsch; 1984 Aug; 41(8):549-53. PubMed ID: 6495232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.